the drug is not yet approved by the U.S
Semaglutide GLP-1 is typically prescribed at higher doses than liraglutide
FDA-approved brand-name GLP-1 medications - Wegovy, Ozempic, Zepbound, Mounjaro - are products the FDA has reviewed as finished products for safety, efficacy, and manufacturing quality
The growing popularity of GLP-1 receptor agonists, especially semaglutide (Ozempic, Wegovy), has been accompanied by considerable social media attention and discussion, from which thorough analyses of user-generated data have emerged highlighting reductions in alcohol motivation, decreased drinking behavior, and altered subjective responses to alcohol (Arillotta et al
On the other hand, IBD patients have lower serum DPP-IV concentrations in comparison with healthy subjects
this situation leads to further inflammation